Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $307,033 - $608,335
19,106 New
19,106 $552,000
Q4 2023

Feb 09, 2024

SELL
$21.58 - $29.5 $314,291 - $429,638
-14,564 Reduced 46.01%
17,089 $462,000
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $601,733 - $932,220
23,323 Added 279.99%
31,653 $938,000
Q2 2023

Aug 14, 2023

SELL
$20.94 - $38.01 $412,203 - $748,226
-19,685 Reduced 70.27%
8,330 $298,000
Q1 2023

May 12, 2023

BUY
$22.92 - $33.76 $642,103 - $945,786
28,015 New
28,015 $657,000
Q2 2022

Aug 12, 2022

BUY
$28.82 - $77.35 $188,482 - $505,868
6,540 New
6,540 $264,000
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $740,182 - $990,481
-7,494 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$109.77 - $165.68 $822,616 - $1.24 Million
7,494 New
7,494 $931,000
Q1 2021

May 14, 2021

SELL
$127.04 - $179.1 $295,368 - $416,407
-2,325 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$99.96 - $135.93 $232,407 - $316,037
2,325 New
2,325 $300,000
Q3 2020

Nov 13, 2020

SELL
$80.32 - $111.8 $581,436 - $809,320
-7,239 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $437,887 - $705,802
7,239 New
7,239 $587,000
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $369,670 - $514,394
-6,214 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$62.59 - $110.3 $92,445 - $162,913
-1,477 Reduced 19.2%
6,214 $397,000
Q2 2019

Aug 14, 2019

SELL
$63.94 - $91.11 $26,599 - $37,901
-416 Reduced 5.13%
7,691 $664,000
Q1 2019

May 13, 2019

BUY
$34.3 - $97.98 $278,070 - $794,323
8,107 New
8,107 $622,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.